Vaccination with formulations targeting Eimeria maxima and Clostridium perfringens conferred comprehensive protection using a dual-infection challenge model of necrotic enteritis

使用针对巨型艾美耳球虫和产气荚膜梭菌的疫苗制剂进行免疫接种,在坏死性肠炎双重感染模型中提供了全面的保护。

阅读:1

Abstract

With increasing regulations restricting antibiotic use in animal feed, the need for alternative strategies to prevent and manage necrotic enteritis (NE) has become imperative. As a result, developing effective vaccines has emerged as a top priority for broiler chicken health management. Coccidial infections are a well-established predisposing factor for NE, underscoring the importance of controlling coccidiosis to help mitigate NE outbreaks. This research aimed to investigate the protective efficacy of vaccine preparations containing Eimeria maxima elongation factor-1α and a multicomponent antigen cocktail of Clostridium perfringens, including a single collagen adhesion protein (CpCna) and two chimeric proteins: CpNA (NetB-Alpha-toxin) and CpFZ (Fructose-1,6-bisphosphate aldolase-Zinc metalloprotease). Two vaccine preparations-recombinant subunit vaccines and DNA vaccines-were developed to assess their immunoprotective effects, determined by relative body weight gain rate, lesion scores, survival rates, and antigen-specific IgY levels using a dual-infection NE challenge model involving E. maxima and C. perfringens. Broilers were administered two subcutaneous immunizations with either adjuvanted proteins or eukaryotic expression plasmids on Days 7 and 17. Chickens vaccinated with the five antigens exhibited significantly higher serum antigen-specific IgY levels, improved weight gains, zero mortality, and reduced lesion scores following the lethal dual-infection challenge. These results indicated that vaccine preparations targeting both C. perfringens and E. maxima represent a promising approach for controlling and preventing coccidiosis-induced NE in chickens.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。